Our
Portfolio

is a digital therapeutics company providing medication management solutions for patients across the healthcare continuum.

develops an artificial mitral valve that can be replaced using a transeptal minimally invasive catheter to help treat patients with heart disease.

is a medical device company developing a miniaturized next-generation mechanical circulatory support system - the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) intended for temporary cardiac support of patients undergoing high-risk coronary interventions and for the treatment of cardiogenic shock.

develops a Healthcare IoT Platform providing healthcare facilities with a comprehensive suite of solutions that caters to every IT need, from healthcare-safe Zero Trust cybersecurity to asset and risk management.

is a medical technology company that develops surgeon-focused AR vision and navigation solutions for ophthalmic surgeries. The company leverages cutting-edge imaging and head-mounted display technologies originally developed for aerospace applications.

is a medical technology company that develops surgeon-focused AR vision and navigation solutions for orthopedics, neurology and general surgeries. The company leverages cutting-edge imaging and head-mounted display technologies originally developed for aerospace applications.

is a femtech company developing AI and biomarkers based platform, leading a paradigm shift in early detection in women’s health.

develops cutting-edge Proteomics AI technology to characterize, analyze, and predict patient response to cancer treatment, enabling personalized treatment strategies with improved outcomes & survival rates.

has created and is constantly advancing the first AI-based language model for primary care, by using medically-informed AI to turn chaotic data into an intuitive and concise patient portrait that gives physicians a deep understanding of their patients' health status.

A research-proven Social Health platform, which addresses the impact of loneliness, social isolation, and other social determinants on the mental and physical health, costs, and engagement of their members and employees.

brings an important innovation to the field of stroke prevention in atrial fibrillation patients, by developing a patented No-Implant, catheter delivered, Left Atrial Appendage (LAA) closure solution designed to reduce stroke risk in patients with non-valvular atrial fibrillation.